pyrimidine has been researched along with Citrullinemia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Cao, D; Chen, C; Chen, L; Chen, X; Hu, X; Kong, F; Li, J; Li, X; Liu, O; Liu, S; Luo, J; Luo, T; Luo, W; Luo, Z; Ma, D; Ming, Z; Peng, K; Wen, M; Xia, L; Xie, Y; Xu, N; Yang, C; Yi, W; Zou, Z | 1 |
Adler, L; Agron, S; Brandis, A; Dimmock, D; Erez, A; Helbling, D; Itzkovitz, S; Korman, S; Nagamani, SC; Rabinovich, S; Ruppin, E; Sarver, A; Silberman, A; Stettner, N; Sun, Q; Ulitsky, I; Yizhak, K | 1 |
2 other study(ies) available for pyrimidine and Citrullinemia
Article | Year |
---|---|
Naturally-occurring spinosyn A and its derivatives function as argininosuccinate synthase activator and tumor inhibitor.
Topics: Adult; Aged; Animals; Argininosuccinate Synthase; Aspartic Acid; Breast; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Citrulline; Citrullinemia; Enzyme Activators; Female; Gene Knockdown Techniques; Gene Knockout Techniques; HEK293 Cells; Humans; Macrolides; Metabolomics; Mice; Middle Aged; Molecular Docking Simulation; Mutation; Protein Binding; Pyrimidines; Recombinant Proteins; Tumor Suppressor Proteins; Xenograft Model Antitumor Assays | 2021 |
Diversion of aspartate in ASS1-deficient tumours fosters de novo pyrimidine synthesis.
Topics: Animals; Argininosuccinate Synthase; Aspartate Carbamoyltransferase; Aspartic Acid; Calcium-Binding Proteins; Carbamoyl-Phosphate Synthase (Glutamine-Hydrolyzing); Cell Line, Tumor; Cell Proliferation; Citrullinemia; Cytosol; Dihydroorotase; Down-Regulation; Enzyme Activation; Humans; Male; Mice; Mice, SCID; Neoplasms; Organic Anion Transporters; Phosphorylation; Pyrimidines; TOR Serine-Threonine Kinases | 2015 |